Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy:: Longitudinal study during pregnancy

被引:57
作者
Alegre, Estibaliz
Diaz-Lagares, Angel
LeMaoult, Joel
Lopez-Moratalla, Natalia
Carosella, Edgardo D.
Gonzalez, Alvaro [1 ]
机构
[1] Univ Navarra Clin, Dept Biochem, Pamplona, Spain
[2] Univ Navarra, Dept Biochem, Pamplona, Spain
[3] Hop St Louis, Inst Univ Hematol, CEA DSV DRM, Serv Rech Hemato Immunol, Paris, France
关键词
abortion; dendritic cells; HLA-G; monocytes; pregnancy;
D O I
10.1016/j.humimm.2007.04.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of this work was to investigate the longitudinal evolution of plasmatic soluble HLA-G (sHLA-G: shed HLA-G1 plus HLA-G5) during pregnancy, and if peripheral maternal antigen presenting cells (APC) can be a source of sHLA-G. Blood samples were obtained from 45 volunteers during normal pregnancy, 8 of them monthly; from 8 pregnant volunteers in the first weeks of pregnancy who had later a miscarriage, and from 14 healthy nonpregnant control women. Monocytes obtained during pregnancy showed a moderately HLA-G cell surface expression and stimulation with interferon (IFN)-gamma increased this expression. Monocytes-derived dendritic cells obtained from pregnant women during the first and third trimester of pregnancy secreted more sHLA-G than those obtained from nonpregnant women. Plasmatic sHLA-G concentration in pregnant women was significatively higher than in nonpregnant women, with a peak in the third month. We can conclude that maternal APC are a source of sHLA-G. Women who experienced miscarriage had previously very tow or undetectable plasmatic sHLA-G Levels in the second month of pregnancy. Data suggest that undetectable sHLA-G could be a risk of complications. (c) 2007 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc.
引用
收藏
页码:661 / 667
页数:7
相关论文
共 45 条
[31]   Determination of soluble HLA-G and HLA-A, -B, and -C molecules in pregnancy [J].
Puppo, F ;
Costa, M ;
Contini, P ;
Brenci, S ;
Cevasco, E ;
Ghio, M ;
Norelli, R ;
Bensussan, A ;
Capitanio, GL ;
Indiveri, F .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (04) :1841-1843
[32]   Association of soluble HLA-G plasma levels with HLA-G alleles [J].
Rebmann, V ;
van der Ven, K ;
Pässler, M ;
Pfeiffer, K ;
Krebs, D ;
Grosse-Wilde, H .
TISSUE ANTIGENS, 2001, 57 (01) :15-21
[33]   Report of the Wet Workshop for Quantification of soluble HLA-G in Essen, 2004 [J].
Rebmann, V ;
LeMaoult, J ;
Rouas-Freiss, N ;
Carosella, ED ;
Grosse-Wilde, H .
HUMAN IMMUNOLOGY, 2005, 66 (08) :853-863
[34]   Detection of soluble HLA-G molecules in plasma and amniotic fluid [J].
Rebmann, V ;
Pfeiffer, K ;
Pässler, M ;
Ferrone, S ;
Maier, S ;
Weiss, E ;
Grosse-Wilde, H .
TISSUE ANTIGENS, 1999, 53 (01) :14-22
[35]   Tolerization of dendritic cells by HLA-G [J].
Ristich, V ;
Liang, SY ;
Zhang, W ;
Wu, J ;
Horuzsko, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (04) :1133-1142
[36]   Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis [J].
RouasFreiss, N ;
Goncalves, RMB ;
Menier, C ;
Dausset, J ;
Carosella, ED .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) :11520-11525
[37]   HLA-G levels in serum and plasma [J].
Rudstein-Svetlicky, N ;
Loewenthal, R ;
Horejsi, V ;
Gazit, E .
TISSUE ANTIGENS, 2006, 67 (02) :111-116
[38]  
Solier C, 2002, EUR J IMMUNOL, V32, P3576, DOI 10.1002/1521-4141(200212)32:12<3576::AID-IMMU3576>3.0.CO
[39]  
2-M
[40]   Placental abruption is associated with decreased maternal plasma levels of soluble HLA-G [J].
Steinborn, A ;
Rebmann, V ;
Scharf, A ;
Sohn, C ;
Grosse-Wilde, H .
JOURNAL OF CLINICAL IMMUNOLOGY, 2003, 23 (04) :307-314